Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which is Best?
Sign Up to like & getrecommendations! Published in 2024 at "Annals of surgery"
DOI: 10.1097/sla.0000000000006609
Abstract: OBJECTIVE To examine the optimal method of assessing response to neoadjuvant therapy (NAT) in operable pancreatic ductal adenocarcinoma (PDAC) patients. SUMMARY OF BACKGROUND DATA PDAC response to NAT is measured with biochemical, radiographic and pathologic… read more here.
Keywords: response neoadjuvant; pathologic response; response; biochemical radiographic ... See more keywords